FO

Fortis Malar Hospitals

FORTISMLR BSE Website Hospital
₹43.10 -0.81 (-1.84%) EOD · 16 Nov 2026
DCF model value ₹51+17.4%
Market price ₹43.10 -0.81 (-1.84%)EOD · 16 Nov 2026
DCF model value

The model puts Fortis Malar Hospitals at ₹51 per share — 17.4% above today's price.

Model estimate · 4 yrs of reported financials · dated 16 Nov 2026

All values are mathematically derived from financial models and do not constitute buy, sell, or hold recommendations. Models rely on historical data and assumptions that may not reflect future outcomes. StockRank is not a registered investment advisor — always do your own research before making investment decisions.

DCF model history

523696 is close to its usual level against the model.It was this cheap or cheaper on 49% of days in the past 5 years.

523696 is in its usual valuation range

Cheaper than on 50% of days over 5 years

Cheap Usual Expensive
Today · 15% below model

After days like today

Cheap days — fewer than two periods in 5 years
Expensive days −4% typical return within 1 d – 4 wk 2 periods in 5 years

Past results do not predict future returns.

360° view

Five pillar scores with 360° stock score 51Value: 47 out of 100. Quality: 44 out of 100. Growth: 25 out of 100. Health: 80 out of 100. Momentum: 58 out of 100. Longer petals indicate higher scores.51 How much you pay for what the business earns and owns, compared with similar companies. How well the business uses its money to earn steady profits and bring in cash. How quickly the business is growing its sales and profits over time. How comfortably the business can pay its bills and manage its debts. Recent share-price moves and changes in earnings and institutional ownership.
✦ AI ANALYSIS

The takeaway

A small multi-specialty hospital operator with a debt-free balance sheet and majority promoter ownership, but sharply declining revenue, negative operating margins and weak share performance make the operating turnaround the central question.

↗ Strengths

  • Reported borrowings are zero and cash was INR 24.7 crore at the latest annual balance date, with a current ratio of 11.33.
  • Promoter holding is 62.7% with no reported pledging as of the latest shareholding date.
  • Latest annual figures show positive returns on equity, capital employed and invested capital, and a Piotroski score of 6.

↘ Risks to watch

  • Revenue contracted sharply over three and five years, and operating cash flow also fell over three years.
  • Operating margin was negative in the latest annual and trailing-twelve-month figures, and the trailing P/E is very high at about 204x.

Fortis Malar Hospitals Limited provides healthcare services in India and operates Fortis Malar Hospital, a multi-specialty hospital in Chennai, offering general medicine and surgery, cardiology, neurology, pediatrics, urology and allied specialties. It was formerly known as Malar Hospital, was incorporated in 1989 and is a subsidiary of Fortis Hospitals Limited. Reported revenue labels cover healthcare services and, in earlier years, in-patient and out-patient categories, all in India.

Key metrics

Latest reported · price-based figures use the EOD quote
Share price multiplied by the number of shares, shown in crore rupees. It measures the market value of equity, not the value of the entire business including debt. 82.30 Cr
Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive. 204.00
Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read. 2.40
Enterprise value relative to trailing 12-month earnings before interest, tax, depreciation and amortisation. It includes debt in valuation but does not account for capital spending or all cash needs. —
Annual dividends per share as a percentage of the share price. Dividends can change, and a falling price can raise the yield. 0.00%
Operating profit relative to the capital used in the business. It indicates capital efficiency, but industry capital needs and accounting values affect comparisons. 13.75%
Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business. 12.04%
Borrowings relative to shareholder equity. More borrowing can increase financing risk; the ratio has different meaning for lenders and is not useful with nonpositive equity. 0.00
The relative strength index compares recent price gains and losses over 14 periods on a 0–100 scale. Extreme readings can persist and do not reliably time a reversal. 61.8
A count of nine accounting checks covering profitability, financial position and operating efficiency. More checks passed does not guarantee future performance, and the measure is less suited to financial businesses. 6 / 9

5 scoring axes

How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.

47/100

How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.

Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read.
2.40×
Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive.
204.00×
P/E divided by the earnings-growth rate used in the ratio. Its meaning depends on that growth period and whether growth is sustainable.
—
Enterprise value relative to trailing 12-month earnings before interest, tax, depreciation and amortisation. It includes debt in valuation but does not account for capital spending or all cash needs.
—
Reported annual operating cash flow as a percentage of current market value of equity. This is before capital spending, so it is not free cash flow.
0.75%
Percentage difference between the saved valuation estimate and its reference share price. It depends on assumptions and is not a forecast return.
15.26%

Profitability, capital efficiency, and consistency of cash generation.

44/100

Profitability, capital efficiency, and consistency of cash generation.

Net profit as a percentage of revenue over the trailing 12 months. Tax, financing and one-off items can affect the margin.
227.78%
Operating profit as a percentage of revenue over the trailing 12 months. It reflects operating profitability before financing and tax, and varies by industry.
-805.56%
A count of nine accounting checks covering profitability, financial position and operating efficiency. More checks passed does not guarantee future performance, and the measure is less suited to financial businesses.
6 / 9
Operating profit relative to the capital used in the business. It indicates capital efficiency, but industry capital needs and accounting values affect comparisons.
13.75%
Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business.
12.04%
Operating cash flow divided by common net profit for the same annual period. It shows how earnings translate into operating cash, but working-capital timing can move the ratio.
0.15×
The share of observed annual periods with positive common earnings within the last ten years. It describes profit frequency, not the size or stability of those profits.
60.00%
The middle annual return on capital employed from the five-year history. It reduces the influence of a single unusual year but can hide recent changes.
-0.88%

Revenue and earnings growth rates across multiple time horizons.

25/100

Revenue and earnings growth rates across multiple time horizons.

Operating cash flow growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
-52.01%
Earnings-per-share growth expressed as a compounded annual rate over three years. Changes in share count and one-off profits can affect the rate.
—
Net profit growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
—
Net profit growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
—
Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
639.60%
Revenue growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
-91.65%
Revenue growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
-76.46%

Balance sheet strength, leverage, and financial stability.

80/100

Balance sheet strength, leverage, and financial stability.

Cash and cash equivalents divided by borrowings. It shows how much borrowing is covered by reported cash, which may not all be freely available.
—
Current assets divided by current liabilities. It describes short-term balance-sheet coverage, but inventories and receivables may not turn into cash quickly.
11.33×
Borrowings relative to shareholder equity. More borrowing can increase financing risk; the ratio has different meaning for lenders and is not useful with nonpositive equity.
0.00×
Earnings available to cover interest expense, expressed as a multiple. It indicates interest-payment capacity but does not cover principal repayments or all cash needs.
0.00×
The share of promoter holdings pledged as collateral. Pledging can create financing pressure if collateral values fall; zero pledging does not remove other risks.
0.00%
The percentage of shares held by promoters. Ownership concentration can align interests but does not by itself establish governance quality.
62.70%

Recent price moves and changes in earnings and institutional ownership.

58/100

Recent price moves and changes in earnings and institutional ownership.

Change in the share of equity held by domestic institutional investors over one year, in percentage points. It describes ownership changes, not the cash they invested or future returns.
0.00 pp
The latest quarterly operating margin minus the average of the preceding four quarters, in percentage points. It describes a margin change, not percentage growth in profit.
17,326.79 pp
Net profit change from the same quarter a year earlier. One-off items and a small comparison-period profit can make the percentage unusually large.
1,877.46%
Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
639.60%
Share-price change over one year. Past price performance does not predict future returns.
-32.94%
Share-price change over three years in total, not per year. Past price performance does not predict future returns.
-41.21%

Peer Companies

Hospital
Financial Statements

Quarterly Results

₹ Cr · per share in ₹
RevenueNet profit ₹ crore
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
− Revenue
Revenue0.000.000.020.020.000.000.000.18
Revenue Growth YoY-100.00%-100.00%————-95.61%639.60%
− Profitability
Operating Profit-0.41-0.37-0.32-0.37-0.33-0.55-0.34-0.23
OPM %——-1572.20%-1491.20%-13260.00%-17719.35%-37333.33%-124.18%
Profit Before Tax0.150.404.280.140.190.110.200.33
− Bottom Line
Net Profit0.010.364.150.010.02-0.040.150.28
Net Profit Growth YoY100.19%-99.33%6538.29%-83.92%100.00%-112.48%-96.33%1877.46%
EPS0.000.192.220.010.01-0.020.080.15
Financial Statements

Income Statement

Annual · ₹ Cr · per share in ₹
RevenueNet profit ₹ crore
ParticularsMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Revenue
Revenue144.59111.8769.2486.1885.9559.010.000.05
Revenue Growth-3.08%-22.63%-38.11%24.47%-0.27%-31.34%-100.00%—
− Expenses & Profitability
Operating Profit-2.43-2.78-6.343.444.57-1.20-2.14-1.58
OPM %-1.57%-2.26%-8.18%3.67%4.94%-1.82%-78.72%-24.80%
Profit Before Tax2.79-11.94-11.31-8.26-7.0150.010.574.73
− Bottom Line
Net Profit2.06-8.89-7.87-8.27-15.4845.320.394.14
Profit Growth-37.95%-531.55%————-99.14%961.54%
EPS1.10-4.75-4.20-4.41-8.2624.180.212.21
Financial Statements

Balance Sheet

Annual · ₹ Cr
Total assetsTotal liabilities ₹ crore

Liabilities shown exclude shareholders’ funds and other equity. Assets equal liabilities plus equity.

ParticularsMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Equity
Shareholders' Funds105.3896.4188.7480.1364.17109.4730.2134.35
− Liabilities
Total Borrowings0.000.000.000.000.000.000.000.00
Total Current Liabilities43.8735.6124.6831.4231.766.416.623.26
Total Liabilities45.4897.1480.3580.7873.836.416.623.26
− Assets
Fixed Assets22.5820.6916.6557.6847.870.000.000.00
Investments0.000.000.000.000.000.000.000.00
Cash & Equivalents6.6443.2613.5712.559.44108.2317.7924.70
Total Current Assets112.1262.0059.9849.0784.48113.2934.1136.90
Total Assets150.85193.55169.10160.91138.00115.8836.8337.60
Financial Statements

Cash Flow

Annual · ₹ Cr
Cash from operationsNet cash flow ₹ crore
ParticularsMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
− Cash Flows
Cash from Operations-15.97-0.30-0.866.845.61-7.301.540.62
Cash from Investing6.3449.88-27.518.230.50119.70-29.100.46
Cash from Financing0.15-11.56-7.25-10.10-12.65-10.85-79.650.00
Net Cash Flow-9.4838.01-35.624.98-6.54101.55-107.211.08
− Cash Position
Closing Cash5.0443.057.4312.405.86107.410.201.29

Shareholding Pattern

Promoters hold 62.7% of Fortis Malar Hospitals, more than half. The split has changed little since Jun 2023.

Fortis Malar Hospitals shareholding by quarter, per cent of shares, oldest first
HolderJun ’23Sep ’23Dec ’23Mar ’24Jun ’24Sep ’24Dec ’24Mar ’25Jun ’25Sep ’25Dec ’25Mar ’26Jun ’26Sep ’26
Promoters62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%62.7%
Indian institutions DII0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
Public37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%37.2%

Darker shading marks the quarters when that holder owned more.

Dividend History

Fortis Malar Hospitals has not paid a dividend in the last 12 months. Its most recent was ₹2.50 per share, with an ex-date of 24 Jul 2024.

Per share, by year

  1. 2026so far —per share no dividend
  2. 2025 —per share no dividend
  3. 2024 ₹42.50per share 2 payments

By calendar year of the ex-date. Records start Apr 2024.

Important Disclaimer

Not SEBI registered. No investment advice. StockRank.in is a software, data, and analytics platform operated by Teleport Creative. We are not registered with the Securities and Exchange Board of India (SEBI) in any capacity — we are not an investment adviser under the SEBI (Investment Advisers) Regulations, 2013, not a research analyst under the SEBI (Research Analysts) Regulations, 2014, and not a stockbroker, portfolio manager, or any other SEBI-regulated intermediary. Content is for general information and education, not personalised investment advice. These disclosures do not limit obligations imposed by applicable law.

No recommendations or solicitation. Valuation estimates, scores, rankings, screeners, charts and AI-generated research are not recommendations, offers or inducements to buy, sell, hold or subscribe to any security. A model estimate or a difference from market price is not a price target or promised return. Research shortlists are not recommended portfolios.

Model outputs are estimates, not facts. Estimates from the DCF valuation model depend on available financial information and assumptions. Frameworks may differ by business type. Models cannot capture every business risk and may rely on delayed or erroneous data. Results can be materially wrong and change as information or methods are updated. AI-generated research can omit context, misinterpret information or produce unsupported statements.

Data provided "as is". Market data displayed on StockRank.in is delayed and not real-time. Price data, financial statements, and derived metrics are sourced from third-party providers believed to be reliable but are provided "as is" and "as available", without warranty of any kind, express or implied — including accuracy, completeness, timeliness, merchantability, or fitness for a particular purpose. Always verify information independently against official sources such as exchange filings and annual reports before acting. Errors and omissions excepted.

Market risk & suitability. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Past performance and model outputs are not indicative of future results, and no returns are assured or guaranteed. Content on this website is generic and does not consider your investment objectives, financial situation, or risk tolerance. Use of this website does not create any adviser-client, fiduciary, or professional relationship. Please consult a SEBI-registered investment adviser before making any investment decision.

No liability. Beware of fraud. To the maximum extent permitted by law, Teleport Creative and StockRank.in shall not be liable for any losses or damages of any kind — direct, indirect, incidental, or consequential, including trading losses and lost profits — arising from the use of, or reliance on, this website. You are solely responsible for your investment decisions. StockRank does not send stock tips, does not operate Telegram or WhatsApp groups, never asks you to transfer funds for investment purposes, and never promises returns — anyone doing so in our name is an impersonator. Read the full Disclosures & Disclaimer